Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 228-940-9 | CAS number: 6375-55-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute Oral Toxicity
LD50 = 2387 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- October 24, 1985
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- 1981
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River France (76410 Saint Aubin les Elbeuf, France)
- Weight at study initiation: between 119 and 184 g for males and between 110 and 155 g for females
- Fasting period before study: yes
- Housing: animals were kept in pre-sterilized polycarbonate cages (five animals per cage) with a size of 42.0 x 27.0 x 15.0 cm covered with a stainless steel wire mesh lid containing food and a water bottle.
- Diet: certified pelleted Rat and Mouse diet Ref A 04C N.A.R. Villemoisson sur Orge, France). Food was given ad libitum during all the study with the exception of the period prior to treatment
- Water: free access to tap water filtered with Millipore filters (0.22 micron) in water bottles.
- Acclimation period: for a minimal period of seven days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 3 °C
- Humidity (%): 50 ± 20 %
- Photoperiod (hrs dark / hrs light): light/dark cycle was 12 hours per day - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): 10 and 20 ml/kg
- Lot/batch no.: batch n o 1178
MAXIMUM DOSE VOLUME APPLIED: 5000 mg/kg, in a volume of 20 ml/kg - Doses:
- 3000, 2000, 1500, 1000, 750 and 500 mg/kg bw
- No. of animals per sex per dose:
- 5 per sex per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed frequently the day of treatment and twice a day during the observation period to note any change in behaviour
or health condition. The mortality was checked daily during the observation period. Bodyweights were recorded on D 1, D 5, D 8, and D 15.
- Necropsy of survivors performed: yes
- Other examinations performed: macroscopic examination of the organs was performed on all animals found dead during the study and those killed by CO2 asphyxiation at the end of the observation period. - Preliminary study:
- Fifteen minutes after dosing at 5000 mg/kg, clonic convulsions were observed in 7 animals, dyspnea and pilo-erection in 3 animals. On Day 2, pilo-erection was observed in the survivor (male 04).
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 2 387 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 1 905.94 - < 3 164.91
- Mortality:
- see tables attached
- Clinical signs:
- other: see tables attached
- Gross pathology:
- see tables attached
- Interpretation of results:
- other: CLP criteria not met
- Conclusions:
- LD50 = 2387 mg/kg bw
- Executive summary:
Method
The study was conducted according to the recommendations of the OECD Guideline N° 401.
Results
The first study was performed at the dose level of 5000 mg/kg bw in distilled water; 7 animals out of 10 died in the first 15 minutes and 2 animals on Day 2.
The second study, therefore, was performed with the following doses in distilled water: 3000, 2000, 1500, 1000, 750 and 500 mg/kg bw. The main clinical sign was chronic convulsions at the dose levels of 5000, 3000 and 2000 mg/kg bw. No clinical sign was observed at the other doses. The bodyweight gain of the survivors was not influenced by the treatment. Macroscopic investigations revealed no lesions in the animals found dead during e study or those sacrificed at the end of the observation period.
Conclusion
LD50 = 2387 mg/kg bw.
Reference
Chronic convulsions were observed 15 mins after gavage at 3000 mg/kg in 8 animals, and at 2000 mg/kg in 3 animals.
On Day 2, no clinical sign was observed. At the dose levels of 1500, 1000, 750 and 500 mg/kg, no clinical sign was recorded.
PATHOLOGICAL EXAMINATIONS
No macroscopic abnormalities were observed at necropsy of the animals found dead during the study or those sacrificed at the end of the observation period. Consequently, no sampling of tissues and no histological investigations were performed.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 387 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The study was conducted according to the recommendations of the OECD Guideline 401.
The first study was performed at the dose level of 5000 mg/kg bw in distilled water; 7 animals out of 10 died in the first 15 minutes and 2 animals on Day 2.
The second study, therefore, was performed with the following doses in distilled water: 3000, 2000, 1500, 1000, 750 and 500 mg/kg bw. The main clinical sign was clonic convulsions at the dose levels of 5000, 3000 and 2000 mg/kg. No clinical sign was observed at the other doses. The bodyweight gain of the survivors was not influenced by the treatment. Macroscopic investigations revealed no lesions in the animals found dead during e study or those sacrificed at the end of the observation period.
The LD50 value calculated in this study was 2387 mg/kg bw.
This result is in line with the one obtained in the supporting study where the LC50 value was greater than 5000 mg/kg bw. Only a short abstract is available for this test.
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE).
In the case of oral exposure route, the acute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories are:
- Category 1: ATE ≤ 5 mg/kg bw
- Category 2: 5 < ATE ≤ 50 mg/kg bw
- Category 3: 50 < ATE ≤ 300 mg/kg bw
- Category 4: 300 < ATE ≤ 2000 mg/kg bw
The acute oral LD50 in rats was established to be greather than 2000 mg/kg bw (2387 mg/kg bw), therefore, the substance is not classified for acute toxicity, according to the CLP Regulation (EC n. 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.